Company Overview and News

 
Why Vedanta could gain out of Electrosteel acquisition

20h moneycontrol
For Vedanta, acquisition of Electrosteel could be value accretive considering that the company has got ready iron ore mines around the latter's plant thus reducing the overall cost and generate better returns owing to forward integration into the steel manufacturing. Moreover, valuation at which the deal is supposed to be concluded is attractive for the existing shareholders of Vedanta.
Upvote Downvote

 
Market Update: IT stocks rally with TCS gaining over 6%; Welspun India zooms 9%; Yes Bank top loser

2018-04-20 moneycontrol
The Indian equity market was trading on a flat to negative note on Friday afternoon with the Nifty shedding 13 points was trading at 10,551 while the Sensex was down 27 points or 0.08 percent.
Upvote Downvote

 
Market Update: IT stocks rally led by TCS; PSU banks drag as PNB, BOI fall 2-5%; Indigo hits new 52-week high

2018-04-20 moneycontrol
The Indian equity market was trading on a negative note on Friday afternoon with the Nifty shedding 21 points was trading at 10,543 while the Sensex was down 58 points or 0.17 percent.
Upvote Downvote

 
Sensex falls over 50 points on negative global cues, weak rupee

2018-04-20 freepressjournal.in
Mumbai: The benchmark BSE Sensex declined by about 80 points in early session today, in tandem with weak global cues amid rupee’s plunge below the 66 mark. Besides, the release of the minutes of last Monetary Policy Committee (MPC) meeting on April 4-5, indicating the Reserve Bank of India may shift to a hawkish monetary stance in June, weighed on investor sentiment.
Upvote Downvote

 
Market Update: CNX IT jumps 3% as TCS hits record high; Infosys, Hindalco most active

2018-04-20 moneycontrol
The Indian equity market was trading on a negative note on Friday morning with the Nifty shedding 19 points was trading at 10,545 while the Sensex was down 61 points or 0.18 percent.
Upvote Downvote

 
New Millennium Iron Corp. Announces Agreements for Sale of Portion of Multi-User Wharf Capacity at Sept-Îles, Quebec

2018-04-19 globenewswire
CALGARY, Alberta, April 19, 2018 (GLOBE NEWSWIRE) -- New Millennium Iron Corp. (“NML” or the “Company”) (TSX:NML) announced today that it has entered into binding agreements with the Sept-Îles Port Authority (“Port”) and Tacora Resources Inc. (“Tacora”) under which a portion of the Company’s multi-user wharf capacity will be sold to Tacora in conjunction with Tacora’s planned re-start of the Scully Mine located near the town of Wabush, Newfoundland and Labrador.
Upvote Downvote

 
Tata Steel-Thyssenkrupp merger delayed by six months

2018-04-19 livemint
Nashik: Germany’s Thyssenkrupp AG will take till the end of the year to set up its joint venture with Tata Steel UK Ltd, about six months later than it had earlier indicated, as negotiations between the steel makers and their workers are taking longer than estimated.
Upvote Downvote

 
Thyssenkrupp: JV with Tata Steel to be finalised by 2018-end

2018-04-19 moneycontrol
German steel giant Thyssenkrupp expects its proposed joint venture with Tata Steel Europe to be finalised by the end of this calendar year, a senior company official said here today.
Upvote Downvote

 
Metals, IT stocks help Sensex rebound nearly 100 pts; crude drags oil retailers up to 7%

2018-04-19 moneycontrol
The market recouped previous day's losses on Thursday even as crude oil prices hit multi-year highs, with the Sensex gaining nearly 100 points.
Upvote Downvote

 
Closing Bell: Global cues push Sensex, Nifty higher; midcaps outperform

2018-04-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher despite crude oil prices, backed by metals, technology and FMCG stocks.
Upvote Downvote

 
Market Live: TCS up 1% ahead of Q4 nos, Welspun Corp gains 5% on order win

2018-04-19 moneycontrol
"The state-of-the-art facility enables Honeywell to provide enhanced expertise and training capabilities to customers and expand its production range," the company said.
Upvote Downvote

 
Market Update: Hindalco, Vedanta jump 7% as CNX Metal outperforms; UltraTech, Yes Bank top gainers

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 29 points was trading at 10,555 while the Sensex was up 63 points or 0.18 percent.
Upvote Downvote

 
Market Live: Sensex, Nifty continue to trade higher; IndusInd falls 2% post Q4, RIL gains

2018-04-19 moneycontrol
1:52 pm Market Update: The market continued to trade mildly higher, with support from metals, technology and FMCG stocks. It shrugged off higher crude oil prices.
Upvote Downvote

 
Market Update: Metal stocks outshine as NALCO, Hindustan Copper jump 9-12%; HUL hits new 52-week high

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 33 points was trading at 10,560 while the Sensex was up 65 points or 0.19 percent.
Upvote Downvote

 
Market Live: Nifty holds 10,550 amid consolidation; TCS, HCL, Tech Mahindra rally

2018-04-19 moneycontrol
12:55 pm Buzzing: Allied Digital was locked at 10 percent upper circuit after one-time settlement of its dues to State Bank of India for Rs 60.34 crore.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...